Palma, G., Khurshid, F., Lu, K., Woodward, B., & Husain, H. (2021). Selective KRAS G12C inhibitors in non-small cell lung cancer: Chemistry, concurrent pathway alterations, and clinical outcomes. Nature Portfolio.
Cita Chicago Style (17a ed.)Palma, Gabriela, Faisal Khurshid, Kevin Lu, Brian Woodward, y Hatim Husain. Selective KRAS G12C Inhibitors in Non-small Cell Lung Cancer: Chemistry, Concurrent Pathway Alterations, and Clinical Outcomes. Nature Portfolio, 2021.
Cita MLA (8a ed.)Palma, Gabriela, et al. Selective KRAS G12C Inhibitors in Non-small Cell Lung Cancer: Chemistry, Concurrent Pathway Alterations, and Clinical Outcomes. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.